FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jack Erion

Research Profile

Chemicals & Drugs

Concepts & Ideas

Tissue Distribution

Living Beings

Disorders

Procedures

Isotope Labeling

Co-author Network

Publications

TOP 3
Alida C Fröberg; Marion De Jong; Berthold A Nock; Wouter A P Breeman; Jack Erion; Theodosia Maina; Marion Verdijsseldonck; Wouter W de Herder; Aad van Der Lugt; Peter P M Kooij; Eric P Krenning
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
Wouter A P Breeman; A C Fröberg; Erik De Blois; Arthur van Gameren; Marleen Melis; Marion De Jong; T Maina; B A Nock; Jack Erion; H R Mäcke; Eric P Krenning
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.
Monique de Visser; H F Bernard; Jack Erion; Michelle A Schmidt; Ananth Srinivasan; B Waser; Jean Claude Reubi; Eric P Krenning; Marion De Jong
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jack Erion (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Alida C Fröberg; Marion De Jong; Berthold A Nock; Wouter A P Breeman; Jack Erion; Theodosia Maina; Marion Verdijsseldonck; Wouter W de Herder; Aad van Der Lugt; Peter P M Kooij; Eric P Krenning
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging 2009;36(8):1265-72.
2008: Wouter A P Breeman; A C Fröberg; Erik De Blois; Arthur van Gameren; Marleen Melis; Marion De Jong; T Maina; B A Nock; Jack Erion; H R Mäcke; Eric P Krenning
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.
Nuclear medicine and biology 2008;35(8):839-49.
2007: Monique de Visser; H F Bernard; Jack Erion; Michelle A Schmidt; Ananth Srinivasan; B Waser; Jean Claude Reubi; Eric P Krenning; Marion De Jong
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.
European journal of nuclear medicine and molecular imaging 2007;34(8):1228-38.
2007: Paul J J M Janssen; Monique de Visser; Suzanne M Verwijnen; Bert F Bernard; Ananth Srinivasan; Jack Erion; Wouter A P Breeman; Arnold G Vulto; Eric P Krenning; Marion De Jong
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumors.
Cancer biotherapy & radiopharmaceuticals 2007;22(3):374-81.
2007: Gráinne B Biddlecombe; Buck E Rogers; Monique de Visser; Jesse J Parry; Marion De Jong; Jack Erion; Jason S Lewis
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
Bioconjugate chemistry 2007;18(3):724-30.
2006: Astrid Capello; Eric P Krenning; Bert F Bernard; Wouter A P Breeman; Jack Erion; Marion De Jong
Anticancer activity of targeted proapoptotic peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(1):122-9.
2004: Bert Bernard; Astrid Capello; Martin P van Hagen; Wouter A P Breeman; Ananth Srinivasan; Michelle Schmidt; Jack Erion; Arthur van Gameren; Eric P Krenning; Marion De Jong
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):173-80.
2003: Monique de Visser; P J J M Janssen; Ananth Srinivasan; Jean Claude Reubi; B Waser; Jack Erion; Michelle A Schmidt; Eric P Krenning; Marion De Jong
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
European journal of nuclear medicine and molecular imaging 2003;30(8):1134-9.
2003: Samuel achilefu; Ananthacari Srinivasan; Michelle A Schmidt; Hermo N Jimenez; Joseph E Bugaj; Jack Erion
Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Journal of medicinal chemistry 2003;46(15):3403-11.
2003: Wouter A P Breeman; Marion De Jong; Theo J Visser; Jack Erion; Eric P Krenning
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.
European journal of nuclear medicine and molecular imaging 2003;30(6):917-20.
2003: Dik J Kwekkeboom; Willem H Bakker; Boen L Kam; Jaap J M Teunissen; Peter P M Kooij; Wouter W de Herder; Richard A Feelders; C H J van Eijck; Marion De Jong; Ananth Srinivasan; Jack Erion; Eric P Krenning
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2003;30(3):417-22.
2003: Wouter A P Breeman; Katy van der Wansem; Bert F Bernard; Arthur van Gameren; Jack Erion; Theo J Visser; Eric P Krenning; Marion De Jong
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
European journal of nuclear medicine and molecular imaging 2003;30(2):312-5.
2002: Wouter A P Breeman; Marion De Jong; Jack Erion; Joseph E Bugaj; Ananth Srinivasan; Bert F Bernard; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(12):1650-6.
2002: Wen Ping Li; Jason S Lewis; Joonyoung Kim; Joseph E Bugaj; michael Johnson; Jack Erion; Carolyn J Anderson
DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.
Bioconjugate chemistry 2002;13(4):721-8.
2002: Samuel achilefu; Hermo N Jimenez; Richard B Dorshow; Joseph E Bugaj; Elizabeth G Webb; R Randy Wilhelm; Raghavan Rajagopalan; Jill Johler; Jack Erion
Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.
Journal of medicinal chemistry 2002;45(10):2003-15.
2001: Jason S Lewis; Mu Wang; Richard Laforest; F Wang; Jack Erion; Joseph E Bugaj; Ananth Srinivasan; Carolyn J Anderson
Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.
International journal of cancer. Journal international du cancer 2001;94(6):873-7.
2001: Dik J Kwekkeboom; Willem H Bakker; Peter P M Kooij; M W Konijnenberg; Ananth Srinivasan; Jack Erion; Michelle A Schmidt; J L Bugaj; Marion De Jong; Eric P Krenning
[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
European journal of nuclear medicine 2001;28(9):1319-25.
2001: Marion De Jong; Wouter A P Breeman; Bert F Bernard; Willem H Bakker; Michael Schaar; Arthur van Gameren; Joseph E Bugaj; Jack Erion; Michelle Schmidt; Ananth Srinivasan; Eric P Krenning
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
International journal of cancer. Journal international du cancer 2001;92(5):628-33.
2001: Joseph E Bugaj; Jack Erion; michael Johnson; Michelle A Schmidt; Ananth Srinivasan
Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats.
Nuclear medicine and biology 2001;28(3):327-34.
2000: Dik J Kwekkeboom; Willem H Bakker; Peter P M Kooij; Jack Erion; Ananth Srinivasan; Marion De Jong; Jean Claude Reubi; Eric P Krenning
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
European journal of nuclear medicine 2000;27(9):1312-7.
1998: Jean Claude Reubi; Beatrice Waser; Jean-Claude Schaer; U Laederach; Jack Erion; Ananth Srinivasan; Michelle A Schmidt; Joseph E Bugaj
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
European journal of nuclear medicine 1998;25(5):481-90.
1998: LA Bass; M V Lanahan; J R Duncan; Jack Erion; A Srinivasan; M A Schmidt; Carolyn J Anderson
Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.
Bioconjugate chemistry 1998;9(2):192-200.
1998: Marion De Jong; Wouter A P Breeman; Willem H Bakker; Peter P M Kooij; Bert F Bernard; Leo Hofland; Theo J Visser; Ananth Srinivasan; Michelle A Schmidt; Jack Erion; Joseph E Bugaj; Helmut R Mäcke; Eric P Krenning
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
Cancer research 1998;58(3):437-41.
1981: Jack Erion; H Weissbach; N Brot
Ribosomal protein biosynthesis during starvation and refeeding in Tetrahymena pyriformis.
Archives of biochemistry and biophysics 1981;210(2):625-32.
1975: J E Fox; Jack Erion
A cytokinin binding protein from higher plant ribosomes.
Biochemical and biophysical research communications 1975;64(2):694-700.